Arrepath
Biotechnology
Overview
ArrePath rapidly creates oral-small-molecule programs with target-specific AI/ML workflows proven in antibacterial discovery and expanding into new therapeutic areas.
Funding and backers
Backers
1
Insight Partners
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Reprogramming Immunity for Target-Specific Medicines.
Light Horse is a small molecule drug discovery company that is leading the way in a.
Venatorx | New antibacterials for today's and tomorrow's infections.
Oral small molecules engineered for clinically relevant biology. Quarry Thera is reimagining proximity pharmacology to deliver durable…
Unlock enterprise-scale AI with ClearML’s AI Infrastructure Platform. Manage GPU clusters, streamline AI/ML workflows, and deploy GenAI…
Bahto Biosciences develops a non-opioid small-molecule therapeutic for painful peripheral neuropathy.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Insight PartnersVia a fund
812 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely